Rev-ing up post-transcriptional HIV-1 RNA expression

RNA Biology

Volumn 8, Issue 2, 2011, Pages

  Yedavalli, Venkat S R K ^a   Jeang, Kuan Teh ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CRM1; HIV 1; PIMT; Rev; RNA export; TGS1

Indexed keywords

METHYLTRANSFERASE; REV PROTEIN; RNA; VIRUS RNA; CAP BINDING PROTEIN; CAPPED RNA; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1;

GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN MOTIF; REVIEW; RNA TRANSLATION; VIRUS GENOME; VIRUS TRANSCRIPTION; ALTERNATIVE RNA SPLICING; ARTICLE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHYLATION; RNA SPLICING;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

ALTERNATIVE SPLICING; GENE EXPRESSION REGULATION, VIRAL; HIV-1; METHYLATION; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA CAP-BINDING PROTEINS; RNA CAPS; RNA SPLICING; RNA, VIRAL; TRANSCRIPTION, GENETIC;

EID: 79954558328     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.8.2.14803     Document Type: Review

References (65)

1. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication and infectivity. J Virol 1993; 67:6365-78. (Pubitemid 23309100)
2. Dowling D, Nasr-Esfahani S, Tan CH, O'Brien K, Howard JL, Jans DA, et al. HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology 2008; 5:18.
3. Saliou JM, Bourgeois CF, yadi-Ben ML, Ropers D, Jacquenet S, Marchand V, et al. Role of RNA structure and protein factors in the control of HIV-1 splicing. Front Biosci 2009; 14:2714-29.
4. Exline CM, Feng Z, Stoltzfus CM. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 2008; 82:3921-31. (Pubitemid 351521229)
5. Stoltzfus CM, Madsen JM. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr HIV Res 2006; 4:43-55.
6. Madsen JM, Stoltzfus CM. A suboptimal 5′ splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology 2006; 3:10.
7. Kammler S, Otte M, Hauber I, Kjems J, Hauber J, Schaal H. The strength of the HIV-1 3′ splice sites affects Rev function. Retrovirology 2006; 3:89.
8. Chang DD, Sharp PA. Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989; 59:789-95. (Pubitemid 20022369)
9. Nakielny S, Fischer U, Michael WM, Dreyfuss G. RNA transport. Annu Rev Neurosci 1997; 20:269-301.
10. Cullen BR. Nuclear mRNA export: insights from virology. Trends Biochem Sci 2003; 28:419-24. (Pubitemid 36976744)
11. Felber BK, Zolotukhin AS, Pavlakis GN. Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv Pharmacol 2007; 55:161-97.
12. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989; 338:254-7. (Pubitemid 19086926)
13. Jacobson A, Peltz SW. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem 1996; 65:693-739. (Pubitemid 26250623)
14. Fornerod M, Ohno M, Yoshida M, Mattaj IW. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997; 90:1051-60. (Pubitemid 27408519)
15. Neville M, Stutz F, Lee L, Davis LI, Rosbash M. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol 1997; 7:767-75. (Pubitemid 27441831)
16. Stade K, Ford CS, Guthrie C, Weis K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 1997; 90:1041-50. (Pubitemid 27408518)
17. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999; 68:913-63. (Pubitemid 29449212)
18. Shatkin AJ, Manley JL. The ends of the affair: capping and polyadenylation. Nat Struct Biol 2000; 7:838-42.
19. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004; 119:381-92. (Pubitemid 39423840)
20. Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, et al. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004; 330:471-80. (Pubitemid 39572852)
21. Li J, Tang H, Mullen TM, Westberg C, Reddy TR, Rose DW, et al. A role for RNA helicase A in posttranscriptional regulation of HIV type 1. Proc Natl Acad Sci USA 1999; 96:709-14. (Pubitemid 29061273)
22. Nekhai S, Jeang KT. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol 2006; 1:417-26.
23. Yedavalli VS, Jeang KT. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci USA 2010; 107:14787-92.
24. Cougot N, van DE, Babajko S, Seraphin B. 'Captabolism'. Trends Biochem Sci 2004; 29:436-44.
25. Izaurralde E, Lewis J, Gamberi C, Jarmolowski A, McGuigan C, Mattaj IW. A cap-binding protein complex mediating U snRNA export. Nature 1995; 376:709-12.
26. Zolotukhin AS, Michalowski D, Bear J, Smulevitch SV, Traish AM, Peng R, et al. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol 2003; 23:6618-30. (Pubitemid 37075772)
27. Wolff H, Hadian K, Ziegler M, Weierich C, Kramer- Hammerle S, Kleinschmidt A, et al. Analysis of the influence of subcellular localization of the HIV Rev protein on Rev-dependent gene expression by multifluorescence live-cell imaging. Exp Cell Res 2006; 312:443-56. (Pubitemid 41804109)
28. Mouaikel J, Verheggen C, Bertrand E, Tazi J, Bordonne R. Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is localized to the nucleolus. Mol Cell 2002; 9:891-901. (Pubitemid 34454898)
29. Lemm I, Girard C, Kuhn AN, Watkins NJ, Schneider M, Bordonne R, et al. Ongoing U snRNP biogenesis is required for the integrity of Cajal bodies. Mol Biol Cell 2006; 17:3221-31. (Pubitemid 43993522)
30. Hausmann S, Ramirez A, Schneider S, Schwer B, Shuman S. Biochemical and genetic analysis of RNA cap guanine-N2 methyltransferases from Giardia lamblia and Schizosaccharomyces pombe. Nucleic Acids Res 2007; 35:1411-20. (Pubitemid 46592864)
31. Franke J, Gehlen J, Ehrenhofer-Murray AE. Hypermethylation of yeast telomerase RNA by the snRNA and snoRNA methyltransferase Tgs1. J Cell Sci 2008; 121:3553-60.
32. Gallardo F, Olivier C, Dandjinou AT, Wellinger RJ, Chartrand P. TLC1 RNA nucleo-cytoplasmic trafficking links telomerase biogenesis to its recruitment to telomeres. EMBO J 2008; 27:748-57. (Pubitemid 351506683)
33. Hausmann S, Zheng S, Costanzo M, Brost RL, Garcin D, Boone C, et al. Genetic and biochemical analysis of yeast and human cap trimethylguanosine synthase: functional overlap of 2,2,7-trimethylguanosine caps, small nuclear ribonucleoprotein components, pre-mRNA splicing factors and RNA decay pathways. J Biol Chem 2008; 283:31706-18.
34. Enunlu I, Papai G, Cserpan I, Udvardy A, Jeang KT, Boros I. Different isoforms of PRIP-interacting protein with methyltransferase domain/ trimethylguanosine synthase localizes to the cytoplasm and nucleus. Biochem Biophys Res Commun 2003; 309:44-51. (Pubitemid 36999756)
35. Girard C, Verheggen C, Neel H, Cammas A, Vagner S, Soret J, et al. Characterization of a short isoform of human Tgs1 hypermethylase associating with small nucleolar ribonucleoprotein core proteins and produced by limited proteolytic processing. J Biol Chem 2008; 283:2060-9.
36. Pasquinelli AE, Ernst RK, Lund E, Grimm C, Zapp ML, Rekosh D, et al. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J 1997; 16:7500-10. (Pubitemid 28010509)
37. Saavedra C, Felber B, Izaurralde E. The simian retrovirus- 1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol 1997; 7:619-28. (Pubitemid 27408859)
38. van ZK, Dickmanns A, Fischer U, Luhrmann R, Fanning E. A cytoplasmically anchored nuclear protein interferes specifically with the import of nuclear proteins but not U1 snRNA. J Cell Biol 1993; 121:229-40.
39. Plessel G, Fischer U, Luhrmann R. m3G cap hypermethylation of U1 small nuclear ribonucleoprotein (snRNP) in vitro: evidence that the U1 small nuclear RNA-(guanosine-N2)-methyltransferase is a non-snRNP cytoplasmic protein that requires a binding site on the Sm core domain. Mol Cell Biol 1994; 14:4160-72.
40. Gorlich D, Kraft R, Kostka S, Vogel F, Hartmann E, Laskey RA, et al. Importin provides a link between nuclear protein import and U snRNA export. Cell 1996; 87:21-32. (Pubitemid 26337387)
41. Seto AG, Zaug AJ, Sobel SG, Wolin SL, Cech TR. Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle. Nature 1999; 401:177-80. (Pubitemid 29436322)
42. Boulon S, Verheggen C, Jady BE, Girard C, Pescia C, Paul C, et al. PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli. Mol Cell 2004; 16:777-87. (Pubitemid 39586535)
43. Ohno M, Segref A, Bachi A, Wilm M, Mattaj IW. PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. Cell 2000; 101:187-98. (Pubitemid 32004746)
44. Sleeman J. A regulatory role for CRM1 in the multidirectional trafficking of splicing snRNPs in the mammalian nucleus. J Cell Sci 2007; 120:1540-50. (Pubitemid 46831784)
45. Terns MP, Grimm C, Lund E, Dahlberg JE. A common maturation pathway for small nucleolar RNAs. EMBO J 1995; 14:4860-71.
46. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999; 96:9112-7. (Pubitemid 29374716)
47. Schutz S, Chemnitz J, Spillner C, Frohme M, Hauber J, Kehlenbach RH. Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway. J Mol Biol 2006; 358:997-1009.
48. Darzynkiewicz E, Stepinski J, Ekiel I, Jin Y, Haber D, Sijuwade T, et al. Beta-globin mRNAs capped with m7G, m2.7(2)G or m2.2.7(3)G differ in intrinsic translation efficiency. Nucleic Acids Res 1988; 16:8953-62.
49. Cai A, Jankowska-Anyszka M, Centers A, Chlebicka L, Stepinski J, Stolarski R, et al. Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation. Biochemistry 1999; 38:8538-47.
50. HsuChen CC, Dubin DT. Di-and trimethylated congeners of 7-methylguanine in Sindbis virus mRNA. Nature 1976; 264:190-1.
51. van Duijn LP, Kasperaitis M, Ameling C, Voorma HO. Additional methylation at the N(2)-position of the cap of 26S Semliki Forest virus late mRNA and initiation of translation. Virus Res 1986; 5:61-6.
52. Liou RF, Blumenthal T. trans-spliced Caenorhabditis elegans mRNAs retain trimethylguanosine caps. Mol Cell Biol 1990; 10:1764-8.
53. Van DK, Hirsh D. mRNAs that mature through trans-splicing in Caenorhabditis elegans have a trimethylguanosine cap at their 5′ termini. Mol Cell Biol 1990; 10:1769-72.
54. Maroney PA, Denker JA, Darzynkiewicz E, Laneve R, Nilsen TW. Most mRNAs in the nematode Ascaris lumbricoides are trans-spliced: a role for spliced leader addition in translational efficiency. RNA 1995; 1:714-23.
55. Gordon RK, Ginalski K, Rudnicki WR, Rychlewski L, Pankaskie MC, Bujnicki JM, et al. Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners. Eur J Biochem 2003; 270:3507-17. (Pubitemid 37046732)
56. Hong JH, Kim SY, Oh CH, Yoo KH, Cho JH. Synthesis and antiviral evaluation of novel openchain analogues of neplanocin A. Nucleosides Nucleotides Nucleic Acids 2006; 25:341-50.
57. De CE. John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity. Nucleosides Nucleotides Nucleic Acids 2005; 24:1395-415.
58. Kim JW, Hong JH. Simple synthesis of novel acyclic (e)-bromovinyl nucleosides as potential antiviral agents. Nucleosides Nucleotides Nucleic Acids 2006; 25:879-87.
59. Zhang H, Schinazi RF, Chu CK. Synthesis of neplanocin F analogues as potential antiviral agents. Bioorg Med Chem 2006; 14:8314-22. (Pubitemid 44667546)
60. Blissenbach M, Grewe B, Hoffmann B, Brandt S, Uberla K. Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J Virol 2010; 84:6598-604.
61. Brandt S, Blissenbach M, Grewe B, Konietzny R, Grunwald T, Uberla K. Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathog 2007; 3:54.
62. Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J 2004; 23:2632-40. (Pubitemid 38988234)
63. Cochrane A. How does the journey affect the message(RNA)? RNA Biol 2009; 6:169-70.
64. Bray M, Prasad S, Dubay JW, Hunter E, Jeang KT, Rekosh D, et al. A small element from the Mason- Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 1994; 91:1256-60. (Pubitemid 24058989)
65. Berkowitz RD, Hammarskjold ML, Helga-Maria C, Rekosh D, Goff SP. 5′ regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology 1995; 212:718-23.